Navigation Links
FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable
Date:12/12/2008

CHICAGO, Dec. 12/PRNewswire-FirstCall/ --The Female Health Company (NYSE Alternext: FHC) has announced that the U.S. Food and Drug Administration's (FDA) Obstetrics and Gynecology Devices Advisory Committee has unanimously voted that the company's second-generation female condom, the FC2 Female Condom(R), is approvable with a single condition.

The Advisory Committee voted 15-0 that the product is approvable with the condition that the FC2 Female Condom's instructions for use continue to follow use instructions for the FC Female Condom(R) (FC1 Female Condom) and appropriately identify the study that was performed to establish the comparable safety and effectiveness of FC2 with FC1.

The FDA is not bound by the committee's recommendation, but it takes its advice into consideration when reviewing obstetric and gynecologic devices.

"We are very pleased with today's outcome and look forward to working with the FDA as it continues to review our application for the FC2 Female Condom," said Dr. Mary Ann Leeper, FHC's Senior Strategic Advisor. "We believe that FHC's second-generation female condom can strengthen the fight against AIDS by expanding affordable access to a woman-initiated HIV prevention method."

The company filed the FC2 Female Condom Pre-market Approval Application (PMA) with the FDA on January 7, 2008 and has been working with FDA as it reviewed the application.

The company's first-generation FC1 Female Condom received FDA approval for distribution in the United States in 1993. The FC1 Female Condom is also included in the World Health Organization's (WHO) essential products list for distribution by United Nations (UN) agencies. Since its approval, 165 million FC1 Female Condoms have been distributed in 142 countries.

The FC2 Female Condom data has been reviewed by other public agencies, including the European Uni
'/>"/>

SOURCE Female Health Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
2. AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators
3. New Health Care Advisory Board to Advise PNC on Billing, Payments and Financial Management
4. PharmMD Expands Advisory Board
5. U.S. Labor Secretary Elaine L. Chao announces new membership of OSHA advisory committee
6. Pennsylvania DEP Directs Shadyside Water Supply to Issue Boil Water Advisory
7. Advisory Vote Begins on California Long-Term Care Local
8. Governors Advisory Council on Physical Fitness and Sports Awards Presented by Health
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
10. Medipacs Appoints Advisory Board Members
11. Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... being revitalized and expanded through a U.S.-funded effort ... Internet access and providing cutting-edge skills labs and ... publication by participants of the $130 million Medical ... detailed progress being made at the African institutions. ... today by the journal Academic Medicine . ...
(Date:7/30/2014)... Good Neighbor Community Services announced that ... of Innovations with Ed Begley Jr, airing later ... times TBA. , In this segment, viewers will ... to redefine the traditional approach to serving the ... passion, innovation, determination, excellence, and collaboration, Good Community ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- It can happen in ... television, dresser or computer monitor and gets critically injured when ... a young child should look around their homes and imagine ... child. Imagining it is better than it becoming a reality," ... Physicians, said in a college news release. Between 2009 ...
(Date:7/30/2014)... well as evolutionary changes in a living organismhad been ... the genome. , However, recent studies have shown that ... that arise simultaneously and in close proximity to each ... in regions where chromosomal rearrangements take place. , The ... may one day lead to new cancer therapies, according ...
(Date:7/30/2014)... 2014 Visitors to our region recognize ... to ensure its protection. Bob Kiesendahl, one of the ... the Delaware Highlands Conservancy for donations collected through participation ... donations add up fast, as visitors welcome the opportunity ... River Region. , The Kiesendahl family has owned Woodloch ...
Breaking Medicine News(10 mins):Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:Tip-Over Furniture Can Kill Kids 2Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2
... 30 The American Lung,Association of Iowa will host a week ... 2008. The camp is open for all children with,asthma from ages ... for kids with asthma to spend a week doing,things all other ... Lung Association, "It is a chance for kids to learn that,having ...
... PORTLAND, Ore. Men with a certain type of ... new chemotherapy drug, Sagopilone, plus prednisone in an international ... Institute researchers. , The research involved men with ... has spread beyond the prostate and is not longer ...
... Dynamic Student Services ... ... ) the architectural, planning and interiors,firm, has transformed a shuttered South ... Golden Gate,University (GGU). As the new "front door" for the downtown ...
... masses in the colon is the same for average-risk patients ... who are 50 to 59 years of age, reports a ... the American Gastroenterological Association (AGA) Institute. , Currently, standard ... cancer based on the increasing incidence of colon cancer at ...
... learn CPR/AED, WASHINGTON, May 30 Sudden ... people in this country every year.,Sadly, an astonishing ... arrest,die before reaching a hospital. If ordinary people ... Automated External,Defibrillator (AED), instead of just waiting for ...
... looks hopeful, but it,s still too early to make ... 30 (HealthDay News) -- An antioxidant found in green ... a toxic protein associated with Alzheimer,s and Parkinson,s disease, ... seen in the brains of Alzheimer,s patients and appears ...
Cached Medicine News:Health News:OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer 2Health News:Golden Gate University Opens New Student Services Center 2Health News:Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s 2Health News:Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s 3Health News:National CPR/AED Awareness Week 2Health News:Green Tea Antioxidant May Help Prevent Alzheimer's 2Health News:Green Tea Antioxidant May Help Prevent Alzheimer's 3
(Date:7/30/2014)... and PARIS , July ... REGN ) and Sanofi (EURONEXT: SAN and NYSE: ... 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia ... reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at ... is an investigational monoclonal antibody targeting PCSK9 (proprotein convertase ...
(Date:7/30/2014)... and NEW YORK , July 30, ... developer of new products for oncology supportive care, announced ... , has been featured in an article on OncLive.com ... in Head and Neck Cancers."  Dr. Steve Sonis ... on the growing demand seen in the oncology community ...
(Date:7/30/2014)... ANTONIO , July 30, 2014   ... company focused on innovating lifesaving devices and methods ... $4.5 million in Series A financing, which was ... Proceeds from the deal will allow Bluegrass Vascular ... Access Catheter System, enhance manufacturing capabilities, and proceed ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... 12, 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX), today ... efforts will be presented at the 98th,Annual ... Research,April 14-18, 2007 in Los Angeles, CA., ... Therapy", Heilbut, et.al. (Abstract #1410) will be ...
... Oncology Portfolio, SOUTH SAN FRANCISCO, Calif., April ... the presentation of four research projects aimed ... as,potential therapeutics for certain types of cancers ... presentations during,poster sessions from April 16th to ...
Cached Medicine Technology:CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 2CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 3Rigel to Present New Research Programs at AACR Meeting 2Rigel to Present New Research Programs at AACR Meeting 3Rigel to Present New Research Programs at AACR Meeting 4Rigel to Present New Research Programs at AACR Meeting 5
1.0 mm diameter head, 0.75 mm deep bite....
Target illumination for day and night testing. Glare luminance distance. The Optec 3500 remote control offers flexible positioning during test administration. Each vision tester includes 12 tests sli...
Stainless steel flexible ruler. graduated in 1/32 inches (.8 mm) fractions, as well as mm graduations....
Colorado Microneedles offer the surgeon precision in cutting and coagulation, without the expense and inconvenience of a laser. The needles may also be used for dissecting large areas such as the sca...
Medicine Products: